ARCHIVES

Patient Advocacy: FDA, NCI Developing Methods For Naming Survivors To Boards

This article is from The Cancer Letter archive.

Vol. 23 No. 05 | February 7, 1997

Download PDF Visit The Full Archive

Related Articles

House Subcommittee Rejects Doubling Budget For Cancer Research, Provides Increase To NIH

July 17, 2009

Funding Opportunities

October 18, 2002

Economic Analysis Finds Erlotinib Marginally Cost-Effective For NSCLC

February 26, 2010

November issue of Business & Regulatory Report included.

November 28, 2003

CCRU, CCSP Projects Described; Plans Listed for DRCCA Applications Branch

November 11, 1983

In Brief: NIH Budget Cut Being Considered, Threatening NCI’s Plan For Reaching Year 2000 Goals

December 13, 1984